Literature DB >> 24448432

Acute inferior myocardial infarction in a young male patient associated with Behcet's disease and sildenafil.

Mustafa Cetin1, Unal Ozturk, Musa Cakici, Emrah Yildiz.   

Abstract

Behcet's disease (BD) is a multisystemic inflammatory disorder of unknown origin, presenting with mucocutaneous, ocular, articular, vascular, gastrointestinal and central nervous system manifestations. Coronary involvement is very rare in patients with BD. Sildenafil, an oral drug used to treat erectile dysfunction, was shown to cause significant cardiovascular problems including acute myocardial infarction (MI) and sudden cardiac death. Acute MI associated with BD and sildenafil has not been reported previously. We present a case of a 23-year-old male patient with an acute inferior MI associated with BD diagnosed after admission of sildenafil, who was successfully treated with thrombus aspiration and tirofiban administration.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24448432      PMCID: PMC3902447          DOI: 10.1136/bcr-2013-201189

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  20 in total

1.  Vascular Behçet's disease with coronary artery aneurysm.

Authors:  Kumiko Arishiro; Jin Nariyama; Masaaki Hoshiga; Atushi Nakagawa; Taichi Okabe; Takahiro Nakakoji; Nobuyuki Negoro; Tadashi Ishihara; Toshiaki Hanafusa
Journal:  Intern Med       Date:  2006-09-01       Impact factor: 1.271

2.  Coronary artery ectasia in a patient with Behcet's disease.

Authors:  Ersan Tatli; Huseyin Surucu; Meryem Aktoz; Mutlu Buyuklu
Journal:  Saudi Med J       Date:  2007-08       Impact factor: 1.484

3.  Thrombus aspiration during primary percutaneous coronary intervention.

Authors:  Tone Svilaas; Pieter J Vlaar; Iwan C van der Horst; Gilles F H Diercks; Bart J G L de Smet; Ad F M van den Heuvel; Rutger L Anthonio; Gillian A Jessurun; Eng-Shiong Tan; Albert J H Suurmeijer; Felix Zijlstra
Journal:  N Engl J Med       Date:  2008-02-07       Impact factor: 91.245

Review 4.  Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease.

Authors: 
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

5.  2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (updating the 2005 Guideline and 2007 Focused Update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Frederick G Kushner; Mary Hand; Sidney C Smith; Spencer B King; Jeffrey L Anderson; Elliott M Antman; Steven R Bailey; Eric R Bates; James C Blankenship; Donald E Casey; Lee A Green; Judith S Hochman; Alice K Jacobs; Harlan M Krumholz; Douglass A Morrison; Joseph P Ornato; David L Pearle; Eric D Peterson; Michael A Sloan; Patrick L Whitlow; David O Williams
Journal:  Circulation       Date:  2009-11-18       Impact factor: 29.690

6.  Acute coronary stenosis in a young man with Behçet's syndrome.

Authors:  Enver Erbilen; Sinan Albayrak; Erim Gulcan; Figen Taser; Serkan Bulur; Hakan Ozhan; Mehmet Yazici
Journal:  Med Princ Pract       Date:  2008-02-19       Impact factor: 1.927

7.  Long term tirofiban infusion before percutaneous coronary intervention in patients with angiographically massive intracoronary thrombus.

Authors:  Timur Timurkaynak; Ugur Arslan; Serhat Balcioglu; Sedat Turkoglu
Journal:  Saudi Med J       Date:  2008-01       Impact factor: 1.484

8.  Coronary artery aneurysms in Behçet's disease.

Authors:  Cihan Cevik; Mohammad Otahbachi; Kenneth Nugent; Leigh Ann Jenkins
Journal:  Cardiovasc Revasc Med       Date:  2009 Apr-Jun

9.  Does sildenafil contribute to acute coronary thrombosis?

Authors:  Ersan Tatlı; Mehmet Akif Çakar; Emir Doğan; Mustafa Alkan
Journal:  Turk Kardiyol Dern Ars       Date:  2012-09

10.  Thrombus aspiration during primary percutaneous coronary intervention improves myocardial reperfusion and reduces infarct size: the EXPIRA (thrombectomy with export catheter in infarct-related artery during primary percutaneous coronary intervention) prospective, randomized trial.

Authors:  Gennaro Sardella; Massimo Mancone; Chiara Bucciarelli-Ducci; Luciano Agati; Raffaele Scardala; Iacopo Carbone; Marco Francone; Angelo Di Roma; Giulia Benedetti; Giulia Conti; Francesco Fedele
Journal:  J Am Coll Cardiol       Date:  2009-01-27       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.